{"id": "1440213701504557068", "creation": 1632208678.0, "user_id": "65890224", "social_network": "twitter", "nsfw": false, "request": ["6701c9aa-27fd-4cef-822d-72fe0c43583a"], "metrics": {"6701c9aa-27fd-4cef-822d-72fe0c43583a": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#Pfizer today announced results from a #COVID19 #vaccine Phase 2/3 trial showing a favorable safety profile and robust neutralizing #antibody responses in #children 5 to 11 years of age using a two-dose regimen of 10 \u00b5g administered 21 days apart, a small\u2026https://t.co/iQqYn6RYmz", "first_save": 1639747523.726789, "hashtags": ["#PFIZER", "#COVID19", "#VACCINE", "#ANTIBODY", "#CHILDREN"]}